References
- Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372:1502–1517.
- McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992; 55:747–752.
- Petzold A, Wattjes MP, Costello F, et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014; 10:447–458.
- Gordon-Lipkin E, Calabresi PA. Optical coherence tomography: a quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis. J Neuroimmunol. 2017; 304:93–96.
- Frohman EM, Fujimoto JG, Frohman TC, et al. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Rev Neurol. 2008; 4:664–675.
- Barkhof F, Calabresi PA, Miller DH, et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol. 2009; 5:256–266.
- Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010; 29:144–168.
- Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69:292–302.
- Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007; 52(Suppl 2): S144–S154.
- Ferreira CS, Beato J, Falcao MS, et al. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations. Retina (Philadelphia, PA). 2017; 37:529–535.
- Ingegnoli F, Gualtierotti R, Pierro L, et al. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study. Microvasc Res. 2015; 97:31–36.
- Altinkaynak H, Duru N, Uysal BS, et al. Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocul Immunol Inflamm. 2016; 24:254–260.
- Akcam HT, Capraz IY, Aktas Z, et al. Multiple sclerosis and optic nerve: an analysis of retinal nerve fiber layer thickness and color Doppler imaging parameters. Eye (Lond). 2014; 28:1206–1211.
- Kal A, Duman E, Sezenoz AS, et al. Evaluation of retrobulbar blood flow and choroidal thickness in patients with rheumatoid arthritis. Int Ophthalmol. 2018; 38:1825–1831.
- Esen E, Sizmaz S, Demir T, et al. Evaluation of choroidal vascular changes in patients with multiple sclerosis using enhanced depth imaging optical coherence tomography. Ophthalmologica. 2016;235:65–71.
- Kal A, Oğuz Ulusoy M, Horasanlı B, et al. Effect of fingolimod (FTY720) on choroidal thickness in patients with multiple sclerosis. Mult Scler Relat Disord. 2017; May14:4–7.
- Tang X, Lan M, Zhang M, et al. Effect of nitric oxide to axonal degeneration in multiple sclerosis via downregulating monocarboxylate transporter 1 in oligodendrocytes. Nitric Oxide. 2017; 67:75–80.
- Luo X, Shen YM, Jiang MN, et al. Ocular blood flow autoregulation mechanisms and methods. J Ophthalmol. 2015;2015:864871
- Abalo-Lojo JM, Limeres CC, Gomez MA, et al. Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients. J Neuroophthalmol. 2014; 34:23–28.
- Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006; 113:324–332.
- Pueyo V, Martin J, Fernandez J, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler. 2008; 14:609–614.
- Balk LJ, Cruz-Herranz A, Albrecht P, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016; 263:1323–1331.